Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain

Paediatr Anaesth. 2002 Nov;12(9):770-4. doi: 10.1046/j.1460-9592.2002.00883.x.

Abstract

Background: This study was conducted to investigate, in vivo, the dose and duration effects of ketamine administration on neuronal degeneration in the developing rat brain.

Methods: Seven-day-old (P7) Sprague-Dawley rats were treated with intraperitoneal injections of ketamine, a noncompetitive N-methyl-D-aspartate receptor antagonist. Degenerating neurones were identified by the cupric-silver stain from 10 brain regions using the stereological disector method.

Results: A single dose of ketamine (25, 50 and 75 mg.kg-1) did not increase neuronal degeneration compared with the saline-treated control. However, repeated doses of ketamine (25 mg.kg-1) at 90-min intervals over 9 h increased degenerating neurones in seven out of 10 brain regions.

Conclusions: These findings suggest that the duration of ketamine exposure correlates with increased neuronal degeneration in the developing rat brain.

MeSH terms

  • Animals
  • Animals, Newborn
  • Brain / drug effects*
  • Brain / growth & development
  • Ketamine / administration & dosage
  • Ketamine / pharmacology*
  • Nerve Degeneration / chemically induced*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*
  • Time Factors

Substances

  • Receptors, N-Methyl-D-Aspartate
  • Ketamine